Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4Lymphoid 1Breast 1

Conditions

Colonic Neoplasms 3Colorectal Neoplasms 2Polyps 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 328Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 257lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
eicosapentaenoic acid ethyl ester × Gastrointestinal × Clear all
NCT03428477 2025-04-18

EMT2

University of Leeds

Phase 3 Active not recruiting
418 enrolled
Gastrointestinal

Colonic Neoplasms

NCT04682665 2024-12-04

Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases

University of Leeds

Completed
81 enrolled
Gastrointestinal

Colonic Neoplasms

NCT04216251 2024-05-03

PREPARE

Massachusetts General Hospital

Phase 1/2 Completed
81 enrolled 11 charts
Gastrointestinal

Colorectal Neoplasms

NCT03661047 2021-11-17

OMICC

Massachusetts General Hospital

Phase 2 Withdrawn
Gastrointestinal

Colonic Neoplasms, Polyps, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡